Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria

Bone Marrow Transplant. 2021 Jun;56(6):1458-1461. doi: 10.1038/s41409-021-01223-y. Epub 2021 Jan 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autografts
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Multiple Myeloma* / therapy
  • Peripheral Blood Stem Cells*
  • Salvage Therapy
  • Transplantation, Autologous